- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.05 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 7 x IMD: IMIDAZOLE(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 3 residues within 4Å:- Chain A: G.56, T.58
- Chain C: Y.51
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:Y.51, A:T.58
GOL.7: 9 residues within 4Å:- Chain A: L.144, F.169, P.170, S.180, L.181, S.182
- Chain B: S.168, S.182, T.184
6 PLIP interactions:3 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:P.170, A:S.180, A:S.182, B:S.168, B:T.184, B:T.184
GOL.20: 4 residues within 4Å:- Chain C: G.40, L.41, D.42, D.90
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:L.41
GOL.27: 3 residues within 4Å:- Chain D: G.56, T.58
- Chain F: Y.51
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:T.58
GOL.28: 11 residues within 4Å:- Chain D: F.169, P.170, V.172, S.180, L.181, S.182
- Chain E: Q.166, E.167, S.168, S.182, T.184
5 PLIP interactions:3 interactions with chain E, 2 interactions with chain D- Hydrogen bonds: E:E.167, E:S.168, E:S.182, D:S.182, D:S.182
GOL.32: 5 residues within 4Å:- Chain B: L.15, G.16, E.17
- Chain E: R.60, V.64
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain B- Hydrogen bonds: E:R.60, E:V.64, B:E.17
- 26 x ZN: ZINC ION(Non-covalent)
ZN.4: 2 residues within 4Å:- Chain A: D.62
- Chain B: D.1
3 PLIP interactions:1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.62, H2O.1, H2O.1
ZN.5: 3 residues within 4Å:- Chain A: E.151, A.171
- Ligands: IMD.2
No protein-ligand interaction detected (PLIP)ZN.6: 1 residues within 4Å:- Chain A: E.46
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:E.46
ZN.10: 5 residues within 4Å:- Chain A: H.167, T.186
- Chain B: N.143, N.144
- Chain D: E.1
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain A- Metal complexes: D:E.1, D:E.1, A:H.167
ZN.11: 3 residues within 4Å:- Chain A: D.104
- Chain B: E.61, S.62
5 PLIP interactions:2 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:E.61, B:E.61, H2O.1, H2O.1, H2O.1
ZN.12: 2 residues within 4Å:- Chain B: D.9
- Ligands: IMD.8
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:D.9
ZN.13: 2 residues within 4Å:- Chain B: K.194, H.195
2 PLIP interactions:1 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.195, H2O.1
ZN.14: 3 residues within 4Å:- Chain A: H.167
- Chain B: D.173
- Chain D: E.1
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:D.173, B:D.173
ZN.15: 2 residues within 4Å:- Chain B: Q.85, E.87
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.87, B:E.87
ZN.16: 3 residues within 4Å:- Chain B: D.66
- Chain E: S.83, Q.85
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain B- Metal complexes: E:S.83, B:D.66
ZN.17: 3 residues within 4Å:- Chain B: K.189, E.193
- Ligands: IMD.9
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:E.193
ZN.24: 2 residues within 4Å:- Chain C: H.38, E.46
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:H.38, C:E.46
ZN.25: 2 residues within 4Å:- Chain C: H.116, V.117
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:H.116
ZN.29: 3 residues within 4Å:- Chain D: E.151, A.171
- Ligands: IMD.26
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:E.151
ZN.30: 2 residues within 4Å:- Chain D: D.62
- Chain E: D.1
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:D.62
ZN.33: 2 residues within 4Å:- Chain E: D.157, H.195
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:D.157, E:H.195
ZN.34: 5 residues within 4Å:- Chain A: E.1
- Chain D: H.167, T.186
- Chain E: N.143, N.144
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain A- Metal complexes: D:H.167, A:E.1, A:E.1
ZN.35: 3 residues within 4Å:- Chain E: S.188, D.191
- Ligands: IMD.31
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:D.191
ZN.36: 2 residues within 4Å:- Chain E: E.61, S.62
3 PLIP interactions:2 interactions with chain E, 1 Ligand-Water interactions- Metal complexes: E:E.61, E:E.61, H2O.1
ZN.37: 3 residues within 4Å:- Chain E: Q.85, A.86, E.87
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:E.87, E:E.87
ZN.38: 1 residues within 4Å:- Chain E: D.9
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:D.9
ZN.39: 3 residues within 4Å:- Chain D: K.132
- Chain E: N.216, E.219
No protein-ligand interaction detected (PLIP)ZN.40: 3 residues within 4Å:- Chain A: E.1
- Chain D: H.167
- Chain E: D.173
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:D.173, E:D.173
ZN.41: 1 residues within 4Å:- Chain E: E.167
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:E.167
ZN.42: 2 residues within 4Å:- Chain E: K.155, E.201
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:E.201, E:E.201
ZN.49: 5 residues within 4Å:- Chain F: R.34, S.36, H.38, E.46, K.95
2 PLIP interactions:2 interactions with chain F- Metal complexes: F:H.38, F:E.46
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 1 residues within 4Å:- Chain C: N.87
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.87
NAG.19: 2 residues within 4Å:- Chain C: V.5, N.111
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.111
NAG.21: 3 residues within 4Å:- Chain C: N.53, Q.57, Q.59
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Q.57
NAG.22: 4 residues within 4Å:- Chain C: N.27, F.29, N.74, E.75
No protein-ligand interaction detected (PLIP)NAG.43: 2 residues within 4Å:- Chain F: N.19, Y.80
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:N.19, F:Y.80
NAG.44: 3 residues within 4Å:- Chain F: Y.85, V.86, N.87
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.87
NAG.45: 1 residues within 4Å:- Chain F: N.111
No protein-ligand interaction detected (PLIP)NAG.46: 2 residues within 4Å:- Chain F: N.53, Q.57
2 PLIP interactions:2 interactions with chain F- Hydrophobic interactions: F:Q.57
- Hydrogen bonds: F:Q.57
NAG.47: 3 residues within 4Å:- Chain F: N.27, N.74, E.75
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:N.27, F:N.74
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Majocchi, S. et al., NI-3201 is a bispecific antibody mediating PD-L1-dependent CD28 costimulation on T cells for enhanced tumor control. Cancer Immunology Research (2024)
- Release Date
- 2024-12-18
- Peptides
- Heavy chain Fab fragment of AI3 antibody: AD
Light chain of AI3 antibody: BE
T-cell-specific surface glycoprotein CD28: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
DB
BE
EC
CF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.05 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 7 x IMD: IMIDAZOLE(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 26 x ZN: ZINC ION(Non-covalent)
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Majocchi, S. et al., NI-3201 is a bispecific antibody mediating PD-L1-dependent CD28 costimulation on T cells for enhanced tumor control. Cancer Immunology Research (2024)
- Release Date
- 2024-12-18
- Peptides
- Heavy chain Fab fragment of AI3 antibody: AD
Light chain of AI3 antibody: BE
T-cell-specific surface glycoprotein CD28: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
DB
BE
EC
CF
F